Cargando…
In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach
Entacapone, a reversible catechol-o-methyl transferase inhibitor, is used to enhance the action of dopamine agonists by reducing their metabolism and the ‘Wearing-off’ effects associated with long-term use in the treatment of Parkinson's disease. It is used as an adjunct to levodopa/Carbidopa t...
Autores principales: | Agrawal, Yogeeta, Patil, Kiran, Mahajan, Hitendra, Potdar, Mrugendra, Joshi, Pratiksha, Nakhate, Kartik, Sharma, Charu, Goyal, Sameer N., Ojha, Shreesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986208/ https://www.ncbi.nlm.nih.gov/pubmed/35380091 http://dx.doi.org/10.1080/10717544.2022.2058651 |
Ejemplares similares
-
Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet
por: Agrawal, Yogeeta O., et al.
Publicado: (2021) -
Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies
por: Agrawal, Yogeeta O, et al.
Publicado: (2020) -
Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery
por: Patil, Tulshidas S., et al.
Publicado: (2023) -
Therapeutic Potential and Pharmaceutical Development of a Multitargeted Flavonoid Phloretin
por: Nakhate, Kartik T., et al.
Publicado: (2022) -
Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders
por: Masule, Milind V., et al.
Publicado: (2022)